The Efficacy of Terazosin in the Management of Chronic Pelvic Pain Syndrome (CPPS): Comparison between Category IIIa and IIIb.
10.4111/kju.2006.47.11.1191
- Author:
Yon Hwan JUNG
1
;
Jong Gu KIM
;
In Rae CHO
Author Information
1. Department of Urology, College of Medicine, Inje University, Busan, Korea.
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
Prostatitis;
Pelvic pain;
Syndrome;
Terazosin
- MeSH:
Humans;
Massage;
Pelvic Pain*;
Prostate;
Prostatitis;
Quality of Life;
Ultrasonography;
Urinalysis
- From:Korean Journal of Urology
2006;47(11):1191-1196
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Purpose: To evaluate the efficacy of terazosin in chronic pelvic pain syndrome (CPPS) and compare the effect of terazosin between CPPS IIIa and IIIb. Materials end Methods: Between January 2004 and February 2005, CPPS patients, aged 45 or below, with a small size prostate (0.05). In category IIIb (n=56), the T group (n=29) showed significant improvements in all NIH-CPSI domains and the Qmax (p<0.05), but the non-T group (n=27) showed no significant improvement in the NIH-CPSI domains or the Qmax (p>0.05). Comparing both category IIIb groups, the T group showed a greater improvement in the pain score in the NIH-CPSI domains and the Qmax than the non-T group. Conclusions: Terazosin was effective in all domains of the symptom score and in the Qmax for CPPS.
